We are sponsoring this event for the 3rd consecutive year. The team at Fleming have put together an impressive speaker panel which you can find here.
Good Pharmacovigilance is based on reliable information leading to an effective assessment of the risk-benefit balance which is crucial both in the clinical development and postmarketing safety of medicines. Therefore, understanding the latest regulations is essential. Pharmacovigilance has radically changed over the last few years, the ever changing global and local regulatory demands have put a lot of stress on the pharmaceutical, biotech companies and all stakeholders involved. Now, more than ever, companies are looking for effective tools to meet the increasing regulatory demands and harmonise PV activities. This premier event aims to give all stakeholders in Pharmacovigilance a better understanding on how to better manage drug safety across the all departments.
